PD-1/PD-L1 interaction inhibitor (Hangzhou Adlai Nortye/Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePD-1/PD-L1 interaction inhibitor (Hangzhou Adlai Nortye/Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College)
Drug Alias NamePD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Hangzhou Adlai Nortye/Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Medicinal Of Biotechnology Chinese Academy Of Medical SciencesHangzhou Adlai Nortye Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A